Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis
Clinical Breast Cancer · 2023-04 · 23 (3) · 281-290
DOI: 10.1016/j.clbc.2022.12.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2023-04. Verfasst von Lu Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China.
- Department of Breast Surgery, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China. Electronic address: biss2007@126.com.
Zitieren
APA
Sun, L., Chen, S., Wang, T., & Bi, S. (2023). Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis. Clinical Breast Cancer, 23(3), 281-290. https://doi.org/10.1016/j.clbc.2022.12.015
Vancouver
Sun L, Chen S, Wang T, Bi S. Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis. Clinical Breast Cancer. 2023;23(3):281-290. doi:10.1016/j.clbc.2022.12.015
BibTeX
@article{Sun2023,
author = {Sun, Lu and Chen, Shuai and Wang, Taiyu and Bi, Shisheng},
title = {Hsa_circ_0008673 Promotes Breast Cancer Progression by MiR-578/GINS4 Axis},
journal = {Clinical Breast Cancer},
year = {2023},
volume = {23},
number = {3},
pages = {281--290},
doi = {10.1016/j.clbc.2022.12.015}
}
EUVIMED